No drugs in development currently target nuclear export specifically
[15] Coverage may continue for type 2 diabetes indication Separate from Highmark policies in PA What This Means for You Check your specific plan: Coverage varies by state, employer, and plan typedon't assume During open enrollment: If your BCBS plan is dropping coverage, explore other insurer options Self-funded employers: Ask HR if your employer is opting to continue GLP-1 coverage Consider alternatives: If you have Type 2 diabetes, Mounjaro (same active ingredient) may still be covered CV indication not yet covered: Despite Lilly's cardiovascular benefits data, no BCBS plans currently cover Zepbound for heart disease or CV risk reductionmost explicitly exclude it [16] CALL YOUR INSURANCE Verify Your Specific Coverage Verify Your Specific Coverage Even though it takes a little more time, we recommend calling so you can speak with a person who may have more information than the online directory or PDF formulary listing

A large observational study Trusted Source The Lancet Go to source recently examined IBD disease course in patients with comorbid type 2 diabetes on GLP-1 therapy versus other antidiabetic treatments
One patient even had anaphylaxis
You can reorder as few as 25 patches for existing designs
In this context, GLP-1 receptor agonists represent one of the most promising pharmacological classes, particularly if challenges related to cost, equitable access, reimbursement policy, and supply constraints are addressed